Loading...
Loading...
Browse all stories on DeepNewz
VisitStanford Unveils Synthetic GPCRs for Programmable Cell Sensing in Nature Biotechnology
Dec 5, 2024, 12:34 PM
A groundbreaking study from Stanford University introduces synthetic G protein-coupled receptors (GPCRs) designed to sense diverse antigens and trigger a range of intracellular responses. These programmable antigen-gated GPCRs (PAGERs), developed by Alice Y. Ting's lab at Stanford, represent a new frontier in programmable sensing and control of cell behavior, potentially revolutionizing immunotherapy and targeted drug delivery. The technology aims to detect both soluble and cell-attached antigens, converting recognition into intracellular responses like transgene expression and real-time monitoring of cellular processes. This innovation, highlighted in Nature Biotechnology, could lead to the development of programmable expression logic gates, offering new tools for prevention-focused healthcare and enhancing the precision of treatments for various diseases.
View original story
Markets
No • 50%
Yes • 50%
Research publications indexed in PubMed or similar databases
No • 50%
Yes • 50%
United States Patent and Trademark Office (USPTO) records
Yes • 50%
No • 50%
Clinical trial registries such as ClinicalTrials.gov
Autoimmune Diseases • 25%
Other • 25%
Cancer • 25%
Infectious Diseases • 25%
Research publications or clinical trial announcements in relevant therapeutic areas
China • 25%
United States • 25%
Other • 25%
European Union • 25%
Regulatory approval announcements from health authorities like FDA, EMA, etc.
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Official press releases or licensing announcements from pharmaceutical companies